Enzyme immunoassay for the quantitative determination of antibodies to Risankizumab (Skyrizi®) in serum and plasma with confirmation. 

This kit has been especially developed for the quantitative determination of antibodies to Risankizumab in serum and plasma.

The Matriks Biotek® Antibody to risankizumab (Skyrizi®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the quantitative determination of antibodies to risankizumab (Skyrizi®) in serum and plasma. It is for professional use only. 

All SHIKARI® ELISA kits are suitable for biosimilar work.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact techsupport@matriksbiotek.com

Matriks Biotek® is a biotechnology company that conducts research on biotechnology, developing products and offering its products at a global scale helping people to lead a better life.